The chief of staff of Hungary's Prime Minster, Gergely Gulyas, said on 14 January 2021 that Hungary has reached a deal with China National Pharmaceutical Group Corp ( Sinopharm) to buy COVID-19 vaccines developed by the company, Reuters news agency reported on Thursday.

According to Gulyas, vaccine shipments under the European Union's programme were arriving to Hungary way too slow.

Gulyas was also quoted as telling a government briefing that the second wave of the COVID-19 pandemic has peaked in Hungary and new infections have dropped but restrictions cannot be eased yet.